
Stuart Snyder
Examiner (ID: 19177)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648 |
| Total Applications | 524 |
| Issued Applications | 295 |
| Pending Applications | 33 |
| Abandoned Applications | 200 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 543310
[patent_doc_number] => 07163818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'Bacteriophage having multiple host range'
[patent_app_type] => utility
[patent_app_number] => 10/350256
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 13936
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10350256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/350256 | Bacteriophage having multiple host range | Jan 20, 2003 | Issued |
Array
(
[id] => 6911873
[patent_doc_number] => 20050175631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Hiv vaccine and method of use'
[patent_app_type] => utility
[patent_app_number] => 10/501606
[patent_app_country] => US
[patent_app_date] => 2003-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9063
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175631.pdf
[firstpage_image] =>[orig_patent_app_number] => 10501606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/501606 | Hiv vaccine and method of use | Jan 13, 2003 | Abandoned |
Array
(
[id] => 43322
[patent_doc_number] => 07776580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Magnetism based rapid cell separation'
[patent_app_type] => utility
[patent_app_number] => 10/538498
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 8655
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776580.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538498
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538498 | Magnetism based rapid cell separation | Dec 30, 2002 | Issued |
Array
(
[id] => 7019268
[patent_doc_number] => 20050221287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation'
[patent_app_type] => utility
[patent_app_number] => 10/500558
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12352
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500558
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500558 | Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation | Dec 30, 2002 | Abandoned |
Array
(
[id] => 366476
[patent_doc_number] => 07479386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-20
[patent_title] => 'HXHV virus, nucleic material, peptide material and uses'
[patent_app_type] => utility
[patent_app_number] => 10/499805
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10807
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/479/07479386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499805 | HXHV virus, nucleic material, peptide material and uses | Dec 26, 2002 | Issued |
Array
(
[id] => 7208072
[patent_doc_number] => 20050053516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Anti-pathogenic composition useful in blood preservation'
[patent_app_type] => utility
[patent_app_number] => 10/496261
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11518
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20050053516.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496261
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496261 | Anti-pathogenic composition useful in blood preservation | Nov 20, 2002 | Issued |
Array
(
[id] => 6912230
[patent_doc_number] => 20050175988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Multiple virus reaction assay'
[patent_app_type] => utility
[patent_app_number] => 10/494896
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9099
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20050175988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494896
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494896 | Multiple virus reaction assay | Nov 7, 2002 | Abandoned |
Array
(
[id] => 7170360
[patent_doc_number] => 20040077831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Method for purifying a biological composition'
[patent_app_type] => new
[patent_app_number] => 10/055143
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16064
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077831.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055143
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055143 | Method for purifying a biological composition | Jan 21, 2002 | Abandoned |
Array
(
[id] => 856618
[patent_doc_number] => 07374875
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Peptides having affinity for the gp120 viral protein and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/466835
[patent_app_country] => US
[patent_app_date] => 2002-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 14182
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/374/07374875.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466835
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466835 | Peptides having affinity for the gp120 viral protein and use thereof | Jan 20, 2002 | Issued |
Array
(
[id] => 243341
[patent_doc_number] => 07589075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Use of an adenosine A3 receptor agonist for inhibition of viral replication'
[patent_app_type] => utility
[patent_app_number] => 10/466263
[patent_app_country] => US
[patent_app_date] => 2002-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4283
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589075.pdf
[firstpage_image] =>[orig_patent_app_number] => 10466263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/466263 | Use of an adenosine A3 receptor agonist for inhibition of viral replication | Jan 12, 2002 | Issued |
Array
(
[id] => 7219460
[patent_doc_number] => 20040072151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Method of extracting virus genes and extraction apparatus'
[patent_app_type] => new
[patent_app_number] => 10/469737
[patent_app_country] => US
[patent_app_date] => 2003-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4607
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469737 | Method of extracting virus genes and extraction apparatus | Mar 15, 2001 | Issued |
Array
(
[id] => 418662
[patent_doc_number] => 07276333
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-10-02
[patent_title] => 'Viral infection inhibitor targeting integrase N-terminal domain'
[patent_app_type] => utility
[patent_app_number] => 09/959936
[patent_app_country] => US
[patent_app_date] => 2000-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 7232
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/276/07276333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959936
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959936 | Viral infection inhibitor targeting integrase N-terminal domain | Apr 24, 2000 | Issued |